These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33363393)

  • 1. COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment.
    Zhu X; Yang L; Huang K
    Diabetes Metab Syndr Obes; 2020; 13():4953-4959. PubMed ID: 33363393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations.
    Cava E; Neri B; Carbonelli MG; Riso S; Carbone S
    Clin Nutr; 2021 Apr; 40(4):1637-1643. PubMed ID: 33765600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
    Sharma JR; Yadav UCS
    Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients.
    Onyango TB; Zhou F; Bredholt G; Brokstad KA; Lartey S; Mohn KG; Özgümüs T; Kittang BR; Linchausen DW; Shafiani S; Elyanow R; Blomberg B; Langeland N; Cox RJ;
    Front Immunol; 2023; 14():1287388. PubMed ID: 38022529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
    Hulme KD; Noye EC; Short KR; Labzin LI
    Front Immunol; 2021; 12():770066. PubMed ID: 34777390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and Risk of COVID-19 Infection and Severity: Available Evidence and Mechanisms.
    Abiri B; Guest PC; Vafa M
    Adv Exp Med Biol; 2021; 1321():97-107. PubMed ID: 33656716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and COVID-19 Pandemics: Epidemiology, Mechanisms, and Management.
    Yang Y; Song Y; Hou D
    Diabetes Metab Syndr Obes; 2023; 16():4147-4156. PubMed ID: 38145256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients.
    Jalaleddine N; Hachim M; Al-Hroub H; Saheb Sharif-Askari N; Senok A; Elmoselhi A; Mahboub B; Samuel Kurien NM; Kandasamy RK; Semreen MH; Halwani R; Soares NC; Al Heialy S
    Front Immunol; 2022; 13():827603. PubMed ID: 35663953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with Severe Obesity during the COVID-19 Pandemic: How to Maintain an Adequate Multidisciplinary Nutritional Rehabilitation Program?
    De Amicis R; Cancello R; Capodaglio P; Gobbi M; Brunani A; Gilardini L; Castenuovo G; Molinari E; Barbieri V; Mambrini SP; Battezzati A; Bertoli S
    Obes Facts; 2021; 14(2):205-213. PubMed ID: 33744894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 on the Destiny of Bariatric Patients.
    Gualtieri P; Marchetti M; Renzo LD; De Santis GL; Palma R; Colica C; Frank G; De Lorenzo A; Di Lorenzo N
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and Obesity: Overlapping of Two Pandemics.
    Gammone MA; D'Orazio N
    Obes Facts; 2021; 14(6):579-585. PubMed ID: 34569546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters.
    Briand F; Sencio V; Robil C; Heumel S; Deruyter L; Machelart A; Barthelemy J; Bogard G; Hoffmann E; Infanti F; Domenig O; Chabrat A; Richard V; Prévot V; Nogueiras R; Wolowczuk I; Pinet F; Sulpice T; Trottein F
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review.
    Moreno-Fernandez J; Ochoa J; Ojeda ML; Nogales F; Carreras O; Díaz-Castro J
    J Physiol Biochem; 2022 Aug; 78(3):581-591. PubMed ID: 35316507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.
    De Lorenzo A; Estato V; Castro-Faria-Neto HC; Tibirica E
    J Inflamm Res; 2021; 14():2267-2276. PubMed ID: 34079332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 and Obesity: "CoVesity"-a Pandemic Within a Pandemic.
    Zakka K; Chidambaram S; Mansour S; Mahawar K; Salminen P; Almino R; Schauer P; Kinross J; Purkayastha S;
    Obes Surg; 2021 Apr; 31(4):1745-1754. PubMed ID: 33479921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of weight changes with SARS-CoV-2 infection and severe COVID-19 outcomes: A nationwide retrospective cohort study.
    Yoon SS; Lim Y; Jeong S; Han HW
    J Infect Public Health; 2023 Dec; 16(12):1918-1924. PubMed ID: 37871359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics.
    Ritter A; Kreis NN; Louwen F; Yuan J
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.